Anagrelide‐induced pericardial effusion in a patient with essential thrombocythemia
Abstract Pericardial effusion leading to cardiac tamponade can occur due to a multitude of etiologies, one of which is medication adverse effects. In patients with comorbid conditions, this can prove to be a challenge in its co‐management along with the primary disease. We present a rare case of ana...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2023-04-01
|
| Series: | Clinical Case Reports |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/ccr3.7246 |
| _version_ | 1797304157424582656 |
|---|---|
| author | David Song Jawad Shabani Vikash Jaiswal Kusum Paudel Arjun Gupta David Rubinstein |
| author_facet | David Song Jawad Shabani Vikash Jaiswal Kusum Paudel Arjun Gupta David Rubinstein |
| author_sort | David Song |
| collection | DOAJ |
| description | Abstract Pericardial effusion leading to cardiac tamponade can occur due to a multitude of etiologies, one of which is medication adverse effects. In patients with comorbid conditions, this can prove to be a challenge in its co‐management along with the primary disease. We present a rare case of anagrelide‐induced pericardial effusion that is presented with tamponade physiology in a patient with essential thrombocythemia. After cautiously weighing the risks and benefits of further invasive interventions following an unsuccessful pericardiocentesis, the decision was to stop anagrelide while managing the pericardial effusion medically. Therefore, managing pericardial effusion should be tailored to each patient individually through shared decision‐making. |
| first_indexed | 2024-03-08T00:05:31Z |
| format | Article |
| id | doaj.art-b5d2f7e6ff414b9698c4bdd74e163988 |
| institution | Directory Open Access Journal |
| issn | 2050-0904 |
| language | English |
| last_indexed | 2024-03-08T00:05:31Z |
| publishDate | 2023-04-01 |
| publisher | Wiley |
| record_format | Article |
| series | Clinical Case Reports |
| spelling | doaj.art-b5d2f7e6ff414b9698c4bdd74e1639882024-02-17T08:51:08ZengWileyClinical Case Reports2050-09042023-04-01114n/an/a10.1002/ccr3.7246Anagrelide‐induced pericardial effusion in a patient with essential thrombocythemiaDavid Song0Jawad Shabani1Vikash Jaiswal2Kusum Paudel3Arjun Gupta4David Rubinstein5Department of Internal Medicine Icahn School of Medicine at Mount Sinai – Elmhurst Hospital Center New York City New York USADepartment of Internal Medicine Icahn School of Medicine at Mount Sinai – Elmhurst Hospital Center New York City New York USADepartment of Cardiovascular Research Larkin Community Hospital Miami Florida USAKathmandu University school of medical sciences Dhulikhel NepalDepartment of Cardiovascular Medicine Icahn School of Medicine at Mount Sinai – Elmhurst Hospital Center New York City New York USADepartment of Cardiovascular Medicine Icahn School of Medicine at Mount Sinai – Elmhurst Hospital Center New York City New York USAAbstract Pericardial effusion leading to cardiac tamponade can occur due to a multitude of etiologies, one of which is medication adverse effects. In patients with comorbid conditions, this can prove to be a challenge in its co‐management along with the primary disease. We present a rare case of anagrelide‐induced pericardial effusion that is presented with tamponade physiology in a patient with essential thrombocythemia. After cautiously weighing the risks and benefits of further invasive interventions following an unsuccessful pericardiocentesis, the decision was to stop anagrelide while managing the pericardial effusion medically. Therefore, managing pericardial effusion should be tailored to each patient individually through shared decision‐making.https://doi.org/10.1002/ccr3.7246adverse effectanagrelideessential thrombocythemiapericardial effusion |
| spellingShingle | David Song Jawad Shabani Vikash Jaiswal Kusum Paudel Arjun Gupta David Rubinstein Anagrelide‐induced pericardial effusion in a patient with essential thrombocythemia Clinical Case Reports adverse effect anagrelide essential thrombocythemia pericardial effusion |
| title | Anagrelide‐induced pericardial effusion in a patient with essential thrombocythemia |
| title_full | Anagrelide‐induced pericardial effusion in a patient with essential thrombocythemia |
| title_fullStr | Anagrelide‐induced pericardial effusion in a patient with essential thrombocythemia |
| title_full_unstemmed | Anagrelide‐induced pericardial effusion in a patient with essential thrombocythemia |
| title_short | Anagrelide‐induced pericardial effusion in a patient with essential thrombocythemia |
| title_sort | anagrelide induced pericardial effusion in a patient with essential thrombocythemia |
| topic | adverse effect anagrelide essential thrombocythemia pericardial effusion |
| url | https://doi.org/10.1002/ccr3.7246 |
| work_keys_str_mv | AT davidsong anagrelideinducedpericardialeffusioninapatientwithessentialthrombocythemia AT jawadshabani anagrelideinducedpericardialeffusioninapatientwithessentialthrombocythemia AT vikashjaiswal anagrelideinducedpericardialeffusioninapatientwithessentialthrombocythemia AT kusumpaudel anagrelideinducedpericardialeffusioninapatientwithessentialthrombocythemia AT arjungupta anagrelideinducedpericardialeffusioninapatientwithessentialthrombocythemia AT davidrubinstein anagrelideinducedpericardialeffusioninapatientwithessentialthrombocythemia |